Algorithmiq, a Helsinki-based startup, has secured $13.7 million in funding to advance its quantum computing solutions aimed at revolutionizing drug discovery and mitigating noise challenges within the field.
Information on the Target
Algorithmiq is a Helsinki-based startup at the forefront of quantum computing, focused on addressing the significant challenges posed by noise in quantum systems. The company aims to demonstrate 'quantum advantage,' which refers to the ability of quantum computers to solve complex problems more efficiently than classical computers. With innovative solutions that don't require the complete removal of noise but rather its mitigation, Algorithmiq is poised to revolutionize the field of quantum computing.
The company’s approach has broad applications, particularly in drug discovery, where it seeks to drastically cut development time and costs by utilizing quantum algorithms, network medicine, and artificial intelligence. The integration of these advanced technologies positions Algorithmiq as a key player in the fast-evolving quantum computing landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
Finland has been a proactive player in the realm of technology and innovation, especially in fields such as quantum computing. The country's robust investment in research and development has created a vibrant ecosystem t
Similar Deals
Indaco Venture Partners, CDP Venture Capital SGR, Freeman Road → Valo Therapeutics Oy
2025
Italian Angels for Growth (IAG) → Sooma Medical
2023
Pathena Fund → Klinik Healthcare Solutions
2023
Nostetta Ventures Oy → Cleamix Oy
2023
Presidio, Tesi, Thames Trust
invested in
Algorithmiq
in 2023
in a Series A deal
Disclosed details
Transaction Size: $14M